Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

717904.pdf (777.28 KB)

Document type

Article

Version

Accepted version

Publication date

2022-10

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/189190

Hospital incidence and medical costs of polycythemia vera in Spain: a retrospective database analysis

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1080/14737167.2022.2029413

Abstract

Polycythemia vera (PV) is one of the most common chronic myeloproliferative neoplasms, yet, little data is available on the epidemiology of PV in Spain and the costs of its management. This study aimed to evaluate the hospital incidence and mortality rate of PV in Spain, and to estimate hospital medical costs.

Subject

Policitèmia, Política sanitària, Cost de l'assistència sanitària

Subject (English)

Polycythemia, Medical policy, Cost of medical care

Citation

Collections

Articles publicats en revistes (Economia)

Citation

DARBÀ, Josep and MARSÀ, Alícia. Hospital incidence and medical costs of polycythemia vera in Spain: a retrospective database analysis. Expert Review of Pharmacoeconomics & Outcomes Research. 2022. Vol. 22, num. 6, pags. 965-970. ISSN 1473-7167. [consulted: 19 of August of 2026]. Available at: https://hdl.handle.net/2445/189190

Export metadata

JSON - METS

Share record